(1) The frequency of the GSTM1(-) in lung cancer and control groups was 56.6% and 57.0% respectively, and no signifcant difference was found between the distribution of the GSTM1(-) genotype in the two groups (χ2=0.831, P=0.362). This evidence concerns the gene GSTM1 and lung carcinoma.